종설 : 야간 혈압의 임상적 의의 = Review : Clinical Significance of Nighttime Blood Pressure

다국어 초록 (Multilingual Abstract)

It was impossible to measure the nighttime blood pressure in patients with hypertension for more than one hundred years. The introduction of ambulatory blood pressure monitoring made it possible to evaluate the nighttime blood pressure and clinical significances in recent 40 years. There are tremendous evidences for proving that the nighttime blood pressure is the more powerful predictor in cardiovascular morbidity and mortality than conventional office and ambulatory daytime blood pressure. The cardiovascular mortality can be reduced when 5% of nighttime blood pressure decreased from Ohasama registry report. So investigators should reevaluate the antihypertensive drugs in the view points of nighttime blood pressure reduction. And changing the administration schedule of antihypertensive drugs, so called chronotherapy, is effective for controlling the nighttime blood pressure and modifying the blood pressure circadian rhythm. Korean Ambulatory Blood Pressure (KORABP), nationwide ambulatory blood pressure monitoring registry in Korea, may answer unproved questions for controlling nighttime blood pressure. (Korean J Med 2011;80:31-35)

참고문헌 (Reference)

1 Pickering TG, "What is white-coat effect and how should it be measured" 7 : 293-300, 2002

2 Hermida RC, "Treatment of non-dipper hypertension with bedtime administration of valsartan" 23 : 1913-1922, 2005

3 Dolan E, "Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: the Dublin outcome study" 46 : 156-161, 2005

4 Fliser D, "Subacute infusion of physiological doses of parathyroid hormone raises blood pressure in humans" 12 : 933-938, 1997

5 Kario K, "Stroke prognosis and abnormal nocturnal blood pressure fall in older hypertensives" 38 : 852-857, 2001

6 Yilmaz MB, "Sleep quality among relatively younger patients with initial diagnosis of hypertension: dippers versus non-dippers" 16 : 101-105, 2007

7 Kapa S, "Sleep apnea and hypertension: interactions and implications for management" 51 : 605-608, 2008

8 Biaggioni I, "Should we target the sympathetic nervous system in the treatment of obesity-associated hypertension" 51 : 168-171, 2008

9 Bakris GL, "Rosiglitazone reduces microalbuminuria and blood pressure independently of glycemia in type 2 diabetes patients with microalbuminuria" 24 : 2047-2055, 2006

10 Ohkubo T, "Relation between nocturnal decline in blood pressure and mortality: the Ohasama study" 10 : 1201-1207, 1997

11 Ohkubo T, "Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study" 20 : 2183-2189, 2002

12 de la Sierra A, "Prevalence and factors associated with circadian blood pressure patterns in hypertensive patients" 53 : 466-472, 2009

13 Hansen TW, "Predictive role of the nighttime blood pressure" 57 : 3-10, 2010

14 Martínez-García MA, "Positive effect of CPAP treatment on the control of difficult-to-treat hypertension" 29 : 951-957, 2007

15 Zeman M, "Plasma melatonin concentrations in hypertensive patients with the dipping and non-dipping blood pressure profile" 76 : 1795-1803, 2005

16 Simko F, "Melatonin as a potential antihypertensive treatment" 42 : 319-322, 2007

17 Tsioufis C, "Managing hypertension in obstructive sleep apnea: the interplay of continuous positive airway pressure, medication and chronotherapy" 28 : 875-882, 2010

18 Vij R, "Management of nocturnal hypertension" 7 : 607-618, 2009

19 Whelton PK, "Effects of oral potassium on blood pressure: meta-analysis of randomized controlled clinical trials" 277 : 1624-1632, 1997

20 O'Brien E, "Dipper and non-dipper" 2 : 397-, 1988

21 Hermida RC, "Differing administration time-dependent effects of aspirin on blood pressure in dipper and non-dipper hypertensives" 46 : 1060-1068, 2005

22 Fagard RH, "Daytime and nighttime blood pressure as predictors of death and cause-specific cardiovascular events in hypertension" 51 : 55-61, 2008

23 Jordan J, "Contrasting effects of vasodilators on blood pressure and sodium balance in the hypertension of autonomic failure" 10 : 35-42, 1999

24 Shibao C, "Clonidine for the treatment of supine hypertension and pressure natriuresis in autonomic failure" 47 : 522-526, 2006

25 Lemmer B, "Clinical chronopharmacology of the cardiovascular system: hypertension and coronary heart disease" 157 : 41-52, 2006

26 Peixoto AJ, "Circadian blood pressure: clinical implications based on the pathophysiology of its variability" 71 : 855-860, 2007

27 Hermida RC, "Chronotherapy improves blood pressure control and reverts the nondipper pattern in patients with resistant hypertension" 51 : 69-76, 2008

28 Banskota NK, "Characterization of induction of protooncogene c-myc and cellular growth in human vascular smooth muscle cells by insulin and IGF-1" 38 : 123-129, 1989

29 Minutolo R, "Changing the timing of antihypertensive therapy to reduce nocturnal blood pressure in CKD: an 8-week uncontrolled trial" 50 : 908-917, 2007

30 Kanbay M, "Causes and mechanisms of nondipping hypertension" 30 : 585-597, 2008

31 Kohara K, "Autonomic nervous function in non-dipper essential hypertensive subjects: evaluation by power spectral analysis of heart rate variability" 26 : 808-814, 1995

32 Pickering TG, "Ambulatory blood pressure monitoring" 354 : 2368-2374, 2006